academic article

• The ENIGMA Consortium: large-scale collaborative analyses of neuroimaging and genetic data..  Brain imaging and behavior.  8:153-182. 2014
• Primary care physicians' familiarity, beliefs, and perceived barriers to practice guidelines in non-diabetic CKD: a survey study..  BMC nephrology.  15:-. 2014
• Attenuated psychosis syndrome in DSM-5..  Schizophrenia research.  150:31-35. 2013
• Catatonia in DSM-5..  Schizophrenia research.  150:26-30. 2013
• Definition and description of schizophrenia in the DSM-5..  Schizophrenia research.  150:3-10. 2013
• Logic and justification for dimensional assessment of symptoms and related clinical phenomena in psychosis: relevance to DSM-5..  Schizophrenia research.  150:15-20. 2013
• Schizoaffective Disorder in the DSM-5..  Schizophrenia research.  150:21-25. 2013
• Structure of the psychotic disorders classification in DSM-5..  Schizophrenia research.  150:11-14. 2013
• Olanzapine and haloperidol in first episode psychosis: two-year data..  Schizophrenia research.  86:234-243. 2006
• Course and predictors of weight gain in people with first-episode psychosis treated with olanzapine or haloperidol..  The British journal of psychiatry : the journal of mental science.  187:537-543. 2005
• Antipsychotic drug effects on brain morphology in first-episode psychosis..  Archives of general psychiatry.  62:361-370. 2005
• Predictors of antipsychotic treatment response in patients with first-episode schizophrenia, schizoaffective and schizophreniform disorders..  The British journal of psychiatry : the journal of mental science.  185:18-24. 2004
• Comparative efficacy and safety of atypical and conventional antipsychotic drugs in first-episode psychosis: a randomized, double-blind trial of olanzapine versus haloperidol..  The American journal of psychiatry.  160:1396-1404. 2003